Total Payments
$5,339
2024 Payments
$734.69
Companies
32
Transactions
282
Medicare Patients
2,395
Medicare Billing
$241,148
Payment Breakdown by Category
Food & Beverage$5,297 (99.2%)
Education$42.02 (0.8%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,297 | 279 | 99.2% |
| Education | $42.02 | 3 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,489 | 93 | $0 (2024) |
| Gilead Sciences, Inc. | $824.67 | 26 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $755.49 | 48 | $0 (2024) |
| Janssen Biotech, Inc. | $241.28 | 13 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $216.54 | 14 | $0 (2023) |
| Janssen Scientific Affairs, LLC | $181.47 | 3 | $0 (2021) |
| UCB, Inc. | $153.50 | 8 | $0 (2020) |
| Allergan Inc. | $144.09 | 9 | $0 (2019) |
| MEDAC PHARMA, INC. | $123.23 | 3 | $0 (2018) |
| PFIZER INC. | $119.32 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $734.69 | 32 | Gilead Sciences, Inc. ($194.28) |
| 2023 | $854.42 | 45 | Takeda Pharmaceuticals U.S.A., Inc. ($227.20) |
| 2022 | $632.35 | 32 | ABBVIE INC. ($302.07) |
| 2021 | $327.29 | 18 | AbbVie Inc. ($89.18) |
| 2020 | $384.32 | 21 | AbbVie Inc. ($129.04) |
| 2019 | $516.07 | 29 | AbbVie, Inc. ($145.13) |
| 2018 | $1,020 | 53 | AbbVie, Inc. ($291.20) |
| 2017 | $870.31 | 52 | Gilead Sciences Inc ($214.61) |
All Payment Transactions
282 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $12.27 | General |
| Category: IMMUNOLOGY | ||||||
| 12/13/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $0.60 | General |
| Category: IMMUNOLOGY | ||||||
| 12/06/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $22.83 | General |
| Category: Immunology | ||||||
| 12/02/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/08/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $26.00 | General |
| 11/01/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $24.32 | General |
| Category: LIVER DISEASE | ||||||
| 10/04/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $11.36 | General |
| Category: IMMUNOLOGY | ||||||
| 10/02/2024 | Gilead Sciences, Inc. | Livdelzi (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: INFLAM | ||||||
| 09/27/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $15.73 | General |
| Category: Immunology | ||||||
| 09/23/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Food and Beverage | In-kind items and services | $90.17 | General |
| Category: LIVER DISEASE | ||||||
| 09/20/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $3.64 | General |
| Category: IMMUNOLOGY | ||||||
| 09/19/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $26.11 | General |
| Category: IMMUNOLOGY | ||||||
| 09/13/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $25.95 | General |
| 09/04/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $14.26 | General |
| Category: IMMUNOLOGY | ||||||
| 08/30/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug), ZERBAXA | Food and Beverage | In-kind items and services | $13.60 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 08/13/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $9.60 | General |
| Category: IMMUNOLOGY | ||||||
| 08/02/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $18.58 | General |
| Category: IMMUNOLOGY | ||||||
| 07/26/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $12.71 | General |
| Category: IMMUNOLOGY | ||||||
| 07/17/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $20.87 | General |
| Category: INTERNAL MEDICINE | ||||||
| 07/17/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Education | In-kind items and services | $13.76 | General |
| Category: INTERNAL MEDICINE | ||||||
| 07/08/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $25.20 | General |
| Category: Immunology | ||||||
| 06/12/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $20.91 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 06/06/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $18.59 | General |
| Category: Immunology | ||||||
| 05/29/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $23.12 | General |
| Category: INTERNAL MEDICINE | ||||||
| 05/17/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Education | In-kind items and services | $13.76 | General |
| Category: INTERNAL MEDICINE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 448 | 469 | $324,532 | $47,930 |
| 2022 | 14 | 525 | 560 | $351,069 | $52,791 |
| 2021 | 15 | 640 | 686 | $377,135 | $67,286 |
| 2020 | 18 | 782 | 813 | $430,028 | $73,140 |
Total Patients
2,395
Total Services
2,528
Medicare Billing
$241,148
Procedure Codes
64
All Medicare Procedures & Services
64 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 68 | 79 | $23,384 | $6,579 | 28.1% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 38 | 38 | $36,290 | $6,245 | 17.2% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 26 | 26 | $40,014 | $4,984 | 12.5% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 29 | 29 | $37,410 | $4,760 | 12.7% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 67 | 68 | $58,344 | $4,655 | 8.0% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 33 | 35 | $39,690 | $3,904 | 9.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 34 | 34 | $13,022 | $3,481 | 26.7% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 20 | 20 | $27,380 | $2,773 | 10.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 31 | 36 | $4,672 | $2,395 | 51.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 17 | 17 | $6,341 | $2,271 | 35.8% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 24 | 26 | $25,974 | $2,192 | 8.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 29 | 29 | $7,337 | $1,700 | 23.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 17 | 17 | $3,519 | $1,333 | 37.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 15 | 15 | $1,155 | $659.23 | 57.1% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 39 | 39 | $37,245 | $6,843 | 18.4% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 66 | 70 | $60,060 | $5,294 | 8.8% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 28 | 29 | $44,631 | $5,166 | 11.6% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 39 | 39 | $44,226 | $5,053 | 11.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 48 | 59 | $15,880 | $4,697 | 29.6% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 24 | 24 | $30,960 | $4,312 | 13.9% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 24 | 24 | $32,856 | $3,303 | 10.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 42 | 51 | $12,551 | $3,229 | 25.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 26 | 26 | $9,958 | $3,010 | 30.2% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 27 | 27 | $6,858 | $2,709 | 39.5% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 33 | 33 | $32,967 | $2,393 | 7.3% |
About Dr. Tarun Sharma, M.D
Dr. Tarun Sharma, M.D is a Gastroenterology healthcare provider based in Kalamazoo, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1790748077.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Tarun Sharma, M.D has received a total of $5,339 in payments from pharmaceutical and medical device companies, with $734.69 received in 2024. These payments were reported across 282 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($5,297).
As a Medicare-enrolled provider, Sharma has provided services to 2,395 Medicare beneficiaries, totaling 2,528 services with total Medicare billing of $241,148. Data is available for 4 years (2020–2023), covering 64 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Kalamazoo, MI
- Active Since 04/08/2006
- Last Updated 03/18/2021
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1790748077
Products in Payments
- Epclusa (Drug) $391.69
- STELARA (Biological) $377.19
- ENTYVIO (Biological) $376.50
- RINVOQ (Biological) $337.87
- Entyvio (Biological) $313.69
- Creon (Drug) $284.69
- XIFAXAN (Drug) $201.30
- LINZESS (Drug) $170.15
- Humira (Biological) $167.75
- HUMIRA (Biological) $161.46
- Cimzia (Drug) $153.50
- SKYRIZI (Biological) $131.07
- Livdelzi (Drug) $125.00
- Rasuvo (Drug) $123.23
- Manometry (Device) $100.01
- ZEPOSIA (Drug) $97.60
- CREON (Drug) $95.87
- REZDIFFRA (Drug) $90.17
- DUPIXENT (Biological) $86.44
- OMVOH (Drug) $79.35
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Kalamazoo
Dr. Kevin Beyer, D.o, D.O
Gastroenterology — Payments: $17,338
Gastroenterology $17,338
Dr. Brij Dewan, M.d, M.D
Gastroenterology — Payments: $10,677
Gastroenterology $10,677
Mark Kocab, Md, MD
Gastroenterology — Payments: $5,563
Gastroenterology $5,563
Dr. Aijaz Turk
Gastroenterology — Payments: $4,468
Gastroenterology $4,468
Eric Sieloff, Md, MD
Gastroenterology — Payments: $3,960
Gastroenterology $3,960
John Quertermus, M.d, M.D
Gastroenterology — Payments: $1,797
Gastroenterology $1,797